Efficacy of perilesional and intralesional triamcinolone acetonide injections in pemphigus vulgaris lesions of the scalp: an effective therapeutic option

Clin Exp Dermatol. 2018 Mar;43(2):168-170. doi: 10.1111/ced.13288. Epub 2017 Oct 10.

Abstract

The scalp is a common location for pemphigus vulgaris (PV), and scalp lesions may be resistant to standard treatment. Perilesional/intralesional triamcinolone acetonide (TA) injections have been used successfully to treat oropharyngeal and ocular involvement in PV. Data on the efficacy of perilesional and intralesional triamcinolone acetonide injections in scalp lesions in PV are lacking. We report two patients with immunopathologically and histopathologically confirmed PV and residual scalp lesions resistant to standard treatment, who were treated with perilesional and intralesional injections of TA 10 mg/mL. Clearance of scalp lesions was achieved after one after, respectively, one and two perilesional and intralesional injections. Perilesional and intralesional TA injections may serve as an effective and safe treatment for recalcitrant scalp lesions in pemphigus.

MeSH terms

  • Adult
  • Female
  • Humans
  • Injections, Intradermal
  • Injections, Intralesional
  • Male
  • Middle Aged
  • Pemphigus / drug therapy*
  • Pemphigus / pathology
  • Scalp Dermatoses / drug therapy*
  • Scalp Dermatoses / pathology
  • Triamcinolone Acetonide / administration & dosage*

Substances

  • Triamcinolone Acetonide